Announcement on Obtaining Approval for Marketing of Chemical API Aprepitant

About this update from Shandong Lukang Pharmaceutical Co., Ltd. Class A

Announcement on Obtaining Approval for Marketing of Chemical API Aprepitant The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Shandong Lukang Pharmaceutical Co., Ltd. Class A